Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 USD | +4.88% | -1.83% | -18.56% |
05-06 | Transcript : Owlet, Inc., Q1 2024 Earnings Call, May 06, 2024 | |
05-06 | Earnings Flash (OWLT) OWLET Reports Q1 Revenue $14.8M, vs. Street Est of $16.4M | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.56% | 38.55M | - | ||
+8.07% | 219B | B | ||
+7.87% | 185B | B- | ||
+12.75% | 135B | B- | ||
-1.37% | 62.21B | A- | ||
+4.88% | 51.01B | B+ | ||
+11.59% | 51.28B | B+ | ||
+2.71% | 41.85B | A | ||
+4.90% | 37.02B | - | ||
+23.75% | 31.27B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- OWLT Stock
- Ratings Owlet, Inc.